Form 4: Orchestra BioMed Exec's RSU Vesting Tax Withholding

Orchestra BioMed Holdings, Inc. Director and COO Darren Sherman reported a disposition of 33,317 shares for tax withholding related to RSU vesting.

Summary

• Darren Sherman, a Director and the President and Chief Operating Officer of Orchestra BioMed Holdings, Inc. (OBIO), reported a transaction involving company common stock.
• On March 25, 2026, 33,317 shares of Common Stock, par value $0.0001 per share, were disposed of.
• This disposition represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units (RSUs).
• No shares were sold in the open market as a result of this RSU vesting and the satisfaction of tax withholding obligations.
• The shares were valued at $4.57 per share for the purpose of tax withholding.
• Following this transaction, Darren Sherman directly beneficially owns 1,204,252 shares of Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. RSU vesting is a positive for the executive, but the tax withholding is a standard, non-discretionary administrative action that does not signal a change in company fundamentals or insider sentiment.

Positives

• The vesting of Restricted Stock Units (RSUs) indicates that previously granted equity compensation has matured, reflecting continued tenure and performance by the executive.
• The transaction was solely for tax withholding purposes, not a discretionary market sale by the insider, which can be viewed as a neutral to slightly positive signal regarding the insider's long-term commitment to the company.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• "Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ('RSUs'). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."

Industry Context

StockSavvy.ai notes that Form 4 filings detailing RSU vesting and associated tax withholdings are routine insider transactions. They typically do not reflect a change in an insider's investment sentiment but rather the standard process of converting equity compensation into vested shares, with a portion withheld to cover statutory tax liabilities. This is a common occurrence across publicly traded companies, especially for executives with significant equity grants.

Stakeholder Impact

• Shareholders: Minimal direct impact. This is a routine administrative transaction for an executive's equity compensation and does not signal a change in company performance or strategy.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary transaction where shares were withheld to cover tax obligations upon RSU vesting. It does not provide new information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than this specific insider filing.

Keywords

Orchestra BioMed Holdings, OBIO, Darren Sherman, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Equity Compensation, Director, Chief Operating Officer